A detailed history of Jaffetilchin Investment Partners, LLC transactions in Viatris Inc stock. As of the latest transaction made, Jaffetilchin Investment Partners, LLC holds 273 shares of VTRS stock, worth $3,502. This represents 0.0% of its overall portfolio holdings.

Number of Shares
273
Holding current value
$3,502
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$10.32 - $12.13 $2,817 - $3,311
273 New
273 $3,000
Q2 2023

Aug 15, 2023

BUY
$9.02 - $10.29 $337,979 - $385,566
37,470 New
37,470 $373,000
Q3 2021

Oct 25, 2021

SELL
$13.25 - $15.13 $157,476 - $179,820
-11,885 Closed
0 $0
Q2 2021

Aug 09, 2021

BUY
$12.97 - $16.15 $154,148 - $191,942
11,885 New
11,885 $223,000
Q1 2021

May 10, 2021

SELL
$13.59 - $18.54 $161,517 - $220,347
-11,885 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$14.3 - $18.74 $169,955 - $222,724
11,885 New
11,885 $223,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.6B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Jaffetilchin Investment Partners, LLC Portfolio

Follow Jaffetilchin Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jaffetilchin Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jaffetilchin Investment Partners, LLC with notifications on news.